CN Patent

CN111184698A — 呋喹替尼制剂及其应用

Assigned to Hutchmed Ltd · Expires 2020-05-22 · 6y expired

What this patent protects

本发明涉及一种呋喹替尼制剂及其应用，特别是用于口服给药的呋喹替尼制剂，其可用于结直肠癌、非小细胞肺癌以及胃癌等癌症的治疗。

USPTO Abstract

本发明涉及一种呋喹替尼制剂及其应用，特别是用于口服给药的呋喹替尼制剂，其可用于结直肠癌、非小细胞肺癌以及胃癌等癌症的治疗。

Drugs covered by this patent

Patent Metadata

Patent number: CN111184698A
Jurisdiction: CN
Classification: —
Expires: 2020-05-22
Drug substance claim: No
Drug product claim: No
Assignee: Hutchmed Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.